Thromboembolism is a well-known complication of the hypercoagulable state associated
with antiphospholipid (aPL) antibodies. Acute respiratory failure (ARF) with diffuse …

The clinical manifestations of antiphospholipid antibody syndrome (APLAS) are protean.
Pulmonary manifestations are often thromboembolic in origin; ARDS and pulmonary …

The presence of antiphospholipid antibodies is associated with arterial and venous
thrombosis. A young female with initial presentation of dyspnea and cough that lasted for …

The antiphospholipid syndrome (APS) is an autoimmune condition in which autoantibodies
directed against certain phospholipid-binding plasma proteins are associated with an …

Pulmonary hemorrhage due to small vessel vasculitis is a well recognized complication of
many autoimmune and collagen vascular disorders. The antiphospholipid antibody …

Pulmonary manifestations in antiphospholipid syndrome (APS) are relatively rare compared
to other clinical signs of this disease. However, pulmonary microthrombosis is among the …

Although antiphospholipid antibody syndrome (APS) is an autoimmune condition that is
primarily characterized by arterial or venous thrombosis or pregnancy morbidity and the …

Antiphospholipid syndrome (APS) is an acquired prothrombotic condition characterized by
vascular thrombosis and/or obstetric complications, in the persistent positivity of circulating …

Pulmonary embolism is the main pulmonary manifestation of primary antiphospholipid
syndrome. Other pulmonary manifestations including intra-alveolar haemorrhage are less …

Antiphospholipid antibody syndrome (APS) has been shown to be associated with arterial
and venous thromboses, recurrent miscarriages, and thrombocytopenia. We describe 3 …